• Home
  • About
    • Our Team
    • Our Partners
  • Our Work
  • Tools
    • Case Definitions
    • Vaccine Safety Templates
    • Translations
  • Resources
    • DSMB Training
    • News
    • Webinars
    • Vaccine Safety Quarterly
    • Safety by Numbers
  • CDC Training​
  • Join
  • SPEAC
Menu
  • Home
  • About
    • Our Team
    • Our Partners
  • Our Work
  • Tools
    • Case Definitions
    • Vaccine Safety Templates
    • Translations
  • Resources
    • DSMB Training
    • News
    • Webinars
    • Vaccine Safety Quarterly
    • Safety by Numbers
  • CDC Training​
  • Join
  • SPEAC
Posted on March 13, 2012September 14, 2023

Immunization site pain

Need for developing a case definition and guidelines for immunization site pain as an adverse event following immunization [AEFI]:...
Read More
Posted on April 13, 2008September 14, 2023

A local reaction at or near injection site

The need for developing a case definition and guidelines for a local reaction at or near the injection site, methods for the devel...
Read More
Posted on August 13, 2007September 14, 2023

Abscess at injection site

Need for developing case definitions and guidelines for abscess at injection site as an adverse events following immunization:...
Read More
Posted on July 13, 2007September 14, 2023

Cellulitis at injection site

Need for developing case definitions and guidelines for cellulitis at injection site as an adverse events following immunization...
Read More
Posted on June 13, 2007September 14, 2023

Induration at or near injection site

Need for developing a standardized case definition and guidelines for induration at or near injection site as an adverse event fol...
Read More
Posted on April 13, 2007September 14, 2023

Swelling at or near injection site

Need for developing a standardized case definition and guidelines for swelling at or near injection site as an adverse events foll...
Read More
Posted on January 13, 2006September 14, 2023

Nodule at injection site as an adverse event following immunization

To improve comparability of vaccine safety data the Brighton Collaboration Local Reactions Working Group has developed a case defi...
Read More

Recent Posts

  • Template protocol for clinical trials investigating vaccines—Focus on safety elementsNovember 21, 2023
  • Safety Platform for Emergency vACcines (SPEAC)November 13, 2023
  • The next generation of pharmacovigilanceNovember 9, 2023
  • Safety by Numbers – October 2023November 8, 2023
  • Request for Review: TTS-VITT Draft Brighton Case DefinitionOctober 31, 2023

Email:
bc-coordinator@taskforce.org

Address:
The Task Force for Global Health,
330 W. Ponce de Leon Ave.
Decatur, GA 30030

  • Case Definitions
  • Safety Templates
  • Covid-19
  • Trusted Sources

© Brighton Collaboration  2023. All rights reserved.

  • Disclaimer and Privacy Policy